Herein, we demonstrated for the first time the key regulatory role of ABHD16A-IFITM1 interaction in HBV infection, which expanded the function of ABHD16A in the innate immune system and provided a new target for the treatment of chronic hepatitis B. The gene discussed is IFITM1; the disease is chronic hepatitis B virus infection.